ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical to Present at Piper Healthcare Conference
|
|
avetis
|
13 |
4.3K |
7 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
13
|
4.3K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Updates Full Year 2023 Guidance
|
|
avetis
|
45 |
15K |
1 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
45
|
15K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Updates Full Year 2023 Guidance
|
|
avetis
|
45 |
15K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
45
|
15K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Updates Full Year 2023 Guidance
|
|
avetis
|
45 |
15K |
3 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
45
|
15K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
RECELL Clinical Education (Warning: Graphic Medical Images)
|
|
avetis
|
39 |
20K |
2 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
39
|
20K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
avetis
|
372 |
138K |
9 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
372
|
138K
|
9
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
avetis
|
372 |
138K |
4 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
372
|
138K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Announces European Distribution Partner
|
|
avetis
|
37 |
10K |
3 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
37
|
10K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Announces European Distribution Partner
|
|
avetis
|
37 |
10K |
3 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
37
|
10K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt
|
|
avetis
|
119 |
37K |
13 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
119
|
37K
|
13
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt
|
|
avetis
|
119 |
37K |
1 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
119
|
37K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt
|
|
avetis
|
119 |
37K |
0 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
119
|
37K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt
|
|
avetis
|
119 |
37K |
2 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
119
|
37K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt
|
|
avetis
|
119 |
37K |
1 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
119
|
37K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
avetis
|
236 |
88K |
3 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
236
|
88K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt
|
|
avetis
|
119 |
37K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
119
|
37K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt
|
|
avetis
|
119 |
37K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
119
|
37K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives Best Product Award at the AAST
|
|
avetis
|
53 |
14K |
1 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
53
|
14K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives Best Product Award at the AAST
|
|
avetis
|
53 |
14K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
53
|
14K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives Best Product Award at the AAST
|
|
avetis
|
53 |
14K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
53
|
14K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical to Present at Cantor Healthcare Conference
|
|
avetis
|
27 |
8.1K |
7 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
27
|
8.1K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Form 8-K
|
|
avetis
|
129 |
35K |
2 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
129
|
35K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Form 8-K
|
|
avetis
|
129 |
35K |
12 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
129
|
35K
|
12
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Form 8-K
|
|
avetis
|
129 |
35K |
1 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
129
|
35K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Form 8-K
|
|
avetis
|
129 |
35K |
1 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
129
|
35K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Form 8-K
|
|
avetis
|
129 |
35K |
8 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
129
|
35K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Form 8-K
|
|
avetis
|
129 |
35K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
129
|
35K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Form 8-K
|
|
avetis
|
129 |
35K |
3 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
129
|
35K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Form 8-K
|
|
avetis
|
129 |
35K |
2 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
129
|
35K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Form 8-K
|
|
avetis
|
129 |
35K |
5 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
129
|
35K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical to Announce Second Quarter 2023 Results
|
|
avetis
|
87 |
33K |
5 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
87
|
33K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical to Announce Second Quarter 2023 Results
|
|
avetis
|
87 |
33K |
6 |
23/07/23 |
23/07/23 |
ASX - By Stock
|
87
|
33K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
avetis
|
144 |
56K |
1 |
15/07/23 |
15/07/23 |
ASX - By Stock
|
144
|
56K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
avetis
|
144 |
56K |
7 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
144
|
56K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
avetis
|
144 |
56K |
3 |
09/07/23 |
09/07/23 |
ASX - By Stock
|
144
|
56K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
avetis
|
144 |
56K |
3 |
09/07/23 |
09/07/23 |
ASX - By Stock
|
144
|
56K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
avetis
|
144 |
56K |
4 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
144
|
56K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
avetis
|
144 |
56K |
5 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
144
|
56K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
avetis
|
144 |
56K |
3 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
144
|
56K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
The near term future
|
|
avetis
|
144 |
56K |
2 |
01/07/23 |
01/07/23 |
ASX - By Stock
|
144
|
56K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives FDA Approval for Full-Thickness Skin
|
|
avetis
|
127 |
42K |
15 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
127
|
42K
|
15
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Announces FDA Approval of RECELL for Vitiligo
|
|
avetis
|
116 |
36K |
5 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
116
|
36K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
avetis
|
233 |
83K |
5 |
18/06/23 |
18/06/23 |
ASX - By Stock
|
233
|
83K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
avetis
|
233 |
83K |
3 |
18/06/23 |
18/06/23 |
ASX - By Stock
|
233
|
83K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
avetis
|
233 |
83K |
6 |
18/06/23 |
18/06/23 |
ASX - By Stock
|
233
|
83K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
avetis
|
233 |
83K |
9 |
17/06/23 |
17/06/23 |
ASX - By Stock
|
233
|
83K
|
9
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
avetis
|
233 |
83K |
5 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
233
|
83K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
avetis
|
233 |
83K |
1 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
233
|
83K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
avetis
|
233 |
83K |
6 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
233
|
83K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives FDA Approval for Full-Thickness Skin
|
|
avetis
|
127 |
42K |
4 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
127
|
42K
|
4
|
|